Latest guidance  

Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib
Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal)
Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer
Kendall DL for ECG monitoring in people having cardiac surgery
Delirium: prevention, diagnosis and management

Latest guidance in consultation  

Intrapartum care: women with existing medical conditions or obstetric complications and their babies
Respiratory tract infections (self-limiting): prescribing antibiotics
Melanoma: assessment and management
Improving outcomes for people with skin tumours including melanoma
Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis

Explore NICE

  1. News|
  2. About|
  3. Events|
  4. Get involved

Latest news  

  1. NICE celebrates its 20th anniversary
  2. Thousands set to benefit from blood pressure treatment under new NICE guidance
  3. 890 more children and adults eligible for cochlear implants on the NHS each year
  4. Local authorities urged to ensure building developers address air pollution

Tweets

by @NICEcomms